For these reasons, surgical teams now routinely screen patients for semaglutide use and implement appropriate protocols based on individual risk assessment
But with seven more Phase 3 trial results expected throughout 2026 and potential approval projected for 2027, it's the drug that weight loss researchers and patients alike are watching most closely
At Omni Medspa, we help you look your best and feel even better starting from the inside out
Saxenda helps people feel fuller and reduces their appetite, making it easier to manage weight
Prices have come down significantly since they were first introduced, and with oral GLP-1 drugs on the horizon, they will likely continue to decline.
Explore Microdosing GLP-1 options here or chat with your Alan Health provider to learn whether microdosing is right for you directly in your portal